Search Results

There are 5061 results for: content related to: Characteristics of adefovir resistance in patients with or without lamivudine-resistant hepatitis B virus treated with adefovir: a 4-year experience

  1. Pharmacokinetics of tacrolimus co-administered with adefovir dipivoxil to liver transplant recipients

    Liver International

    Volume 29, Issue 8, September 2009, Pages: 1178–1183, Norah A. Terrault, Tram T. Tran, Eugene Schiff, Brendan M. McGuire, Robert S. Brown Jr, Rebecca Tupper, Srini Ramanathan, Jeffrey Enejosa, Lijie Zhong, Jian Zong and for the Study 531 Team

    Article first published online : 22 MAY 2009, DOI: 10.1111/j.1478-3231.2009.01998.x

  2. Efficacy of adefovir dipivoxil in the treatment of lamivudine-resistant hepatitis B virus genotype C infection

    Liver International

    Volume 27, Issue 1, February 2007, Pages: 47–53, Do Young Kim, Hong Jeoung Kim, Chun Kyon Lee, Jeong Hun Suh, Dong Hwan Kim, Yong Suk Cho, Sun Young Won, Byung Kyu Park and In Suh Park

    Article first published online : 16 JAN 2007, DOI: 10.1111/j.1478-3231.2006.01407.x

  3. In vitro, ex vivo, and in situ intestinal absorption characteristics of the antiviral ester prodrug adefovir dipivoxil

    Journal of Pharmaceutical Sciences

    Volume 89, Issue 8, August 2000, Pages: 1054–1062, Pieter Annaert, Josef J. Tukker, Jan van Gelder, Lieve Naesens, Erik de Clercq, Guy van den Mooter, Renaat Kinget and Patrick Augustijns

    Article first published online : 18 JUL 2000, DOI: 10.1002/1520-6017(200008)89:8<1054::AID-JPS10>3.0.CO;2-5

  4. Enhanced dissolution and stability of adefovir dipivoxil by cocrystal formation

    Journal of Pharmacy and Pharmacology

    Volume 63, Issue 4, April 2011, Pages: 483–490, Yuan Gao, Hui Zu and Jianjun Zhang

    Article first published online : 1 MAR 2011, DOI: 10.1111/j.2042-7158.2010.01246.x

  5. You have free access to this content
    Complex dynamics of hepatitis B virus resistance to adefovir

    Hepatology

    Volume 49, Issue 1, January 2009, Pages: 50–59, Coralie Pallier, Christophe Rodriguez, Rozenn Brillet, Patrice Nordmann, Christophe Hézode and Jean-Michel Pawlotsky

    Article first published online : 18 SEP 2008, DOI: 10.1002/hep.22634

  6. You have free access to this content
    Resolution of adefovir-related nephrotoxicity by adefovir dose-reduction in patients with chronic hepatitis B

    Alimentary Pharmacology & Therapeutics

    Volume 37, Issue 7, April 2013, Pages: 710–719, J. L. Hartono, M. O. Aung, Y. Y. Dan, M. Gowans, K. Lim, Y. M. Lee, G. H. Lee, H. C. Low, P. S. Tan, M. A. Thwin, C. Soon, L.-L. Chiu, M. J. Khoo, E. Koay and S. G. Lim

    Article first published online : 21 FEB 2013, DOI: 10.1111/apt.12251

  7. You have free access to this content
    Management options for lamivudine-resistant chronic hepatitis B patients with suboptimal virological suppression by adefovir

    Alimentary Pharmacology & Therapeutics

    Volume 34, Issue 8, October 2011, Pages: 972–981, A. Ong, V. W.-S. Wong, G. L.-H. Wong, H.-Y. Chan, C.-H. Tse and H. L.-Y. Chan

    Article first published online : 24 AUG 2011, DOI: 10.1111/j.1365-2036.2011.04833.x

  8. Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2005 update

    Liver International

    Volume 25, Issue 3, June 2005, Pages: 472–489, Yun-Fan Liaw, Nancy Leung, Richard Guan, George K.K. Lau, Ismail Merican, Geoff McCaughan, Edward Gane, Jia-Horng Kao, Masao Omata and for the Asian-Pacific consensus update working party on chronic hepatitis B

    Article first published online : 21 MAY 2005, DOI: 10.1111/j.1478-3231.2005.01134.x

  9. Combination adefovir–lamivudine prevents emergence of adefovir resistance in lamivudine-resistant hepatitis B

    Journal of Gastroenterology and Hepatology

    Volume 22, Issue 9, September 2007, Pages: 1500–1505, David Van Der Poorten, Emilia Prakoso, Teh-Liane Khoo, Meng C Ngu, Geoffrey W McCaughan, Simone I Strasser and Alice U Lee

    Article first published online : 6 AUG 2007, DOI: 10.1111/j.1440-1746.2007.05093.x

  10. You have free access to this content
    Cost-effectiveness analysis of lamivudine and adefovir dipivoxil in the treatment of patients with HBeAg-negative chronic hepatitis B

    Alimentary Pharmacology & Therapeutics

    Volume 23, Issue 3, February 2006, Pages: 409–419, M. BUTI, M. A. CASADO, J. L. CALLEJA, J. SALMERÓN, J. AGUILAR, M. RUEDA and R. ESTEBAN

    Article first published online : 16 JAN 2006, DOI: 10.1111/j.1365-2036.2006.02767.x

  11. Absence of a Pharmacokinetic Interaction Between Entecavir and Adefovir

    The Journal of Clinical Pharmacology

    Volume 47, Issue 10, October 2007, Pages: 1327–1334, Mr Marc Bifano, Dr Jing-He Yan, Dr Robert A. Smith, Dr Duxi Zhang, Dr Dennis M. Grasela and Dr Frank LaCreta

    Article first published online : 7 MAR 2013, DOI: 10.1177/0091270007304780

  12. Systemic and Renal Pharmacokinetics of Adefovir and Tenofovir Upon Coadministration

    The Journal of Clinical Pharmacology

    Volume 45, Issue 8, August 2005, Pages: 935–940, Brian P. Kearney, Srinivasan Ramanathan, Andrew K. Cheng, Ramin Ebrahimi and Jaymin Shah

    Article first published online : 19 MAR 2013, DOI: 10.1177/0091270005278949

  13. Chronic hepatitis B: treatment alert

    Liver International

    Volume 26, Issue S2, December 2006, Pages: 47–58, ACT-HBV Asia-Pacific Steering Committee Members

    Article first published online : 7 NOV 2006, DOI: 10.1111/j.1478-3231.2006.01374.x

  14. You have free access to this content
    Chronic hepatitis B

    Hepatology

    Volume 45, Issue 2, February 2007, Pages: 507–539, Anna S. F. Lok and Brian J. McMahon

    Article first published online : 26 JAN 2007, DOI: 10.1002/hep.21513

  15. Determination of adefovir in human plasma by liquid chromatography/tandem mass spectrometry: application to a pharmacokinetic study

    Rapid Communications in Mass Spectrometry

    Volume 19, Issue 20, 30 October 2005, Pages: 2911–2917, Hui-chang Bi, Guo-ping Zhong, Shufeng Zhou, Xiao Chen and Min Huang

    Article first published online : 16 SEP 2005, DOI: 10.1002/rcm.2141

  16. Viral response at 6 months is associated with treatment outcome of adefovir add-on therapy for lamivudine-resistance

    Journal of Gastroenterology and Hepatology

    Volume 27, Issue 9, September 2012, Pages: 1454–1460, Yu Jin Kim, Seung Woon Paik, Dong Hyun Sinn, Geum-Youn Gwak, Moon Seok Choi, Joon Hyeok Lee, Kwang Cheol Koh and Byung Chul Yoo

    Article first published online : 21 AUG 2012, DOI: 10.1111/j.1440-1746.2011.07050.x

  17. You have free access to this content
    JSH Guidelines for the Management of Hepatitis B Virus Infection

    Hepatology Research

    Volume 44, Issue S1, January 2014, Pages: 1–58, Drafting Committee for Hepatitis Management Guidelines and the Japan Society of Hepatology

    Article first published online : 7 JAN 2014, DOI: 10.1111/hepr.12269

  18. Lamivudine with or without adefovir dipivoxil for postoperative hepatocellular carcinoma

    Intervention Review

    The Cochrane Library

    Jian Hong Zhong, Le Qun Li and Liu Cheng Wu

    Published Online : 7 DEC 2011, DOI: 10.1002/14651858.CD008713.pub2

  19. Hepatitis B e antigen-suppressing mutations enhance the replication efficiency of adefovir-resistant hepatitis B virus strains

    Journal of Viral Hepatitis

    Volume 20, Issue 2, February 2013, Pages: 141–148, U. Herbers, S. Amini-Bavil-Olyaee, A. Mueller, T. Luedde, C. Trautwein and F. Tacke

    Article first published online : 3 JUL 2012, DOI: 10.1111/j.1365-2893.2012.01639.x

  20. You have free access to this content
    Characterization of the dynamics of hepatitis B virus resistance to adefovir by ultra-deep pyrosequencing

    Hepatology

    Volume 58, Issue 3, September 2013, Pages: 890–901, Christophe Rodriguez, Stéphane Chevaliez, Paul Bensadoun and Jean-Michel Pawlotsky

    Article first published online : 30 JUL 2013, DOI: 10.1002/hep.26383